[How to manage EBV reactivation and EBV-PTLD, CMV and human herpesvirus 6 reactivation and infection after allogeneic stem cell transplantation: A report of the SFGM-TC (update)].

Eolia Brissot Tamim Alsuliman Bérengère Gruson Eric Hermet Yordanka Tirefort Ibrahim Yakoub-Agha Sophie Alain

Bull Cancer

Université de Limoges, faculté de médecine, 2, rue du docteur Marcland, 87025 Limoges, France; CHU de Limoges, service de bactériologie virologie-hygiène, 2, avenue Martin-Luther-King, 87042 Limoges, France; Centre national de référence des cytomégalovirus, 87000 Limoges, France; Inserm UMR 1092, 87000 Limoges, France.

Published: December 2017

The French society of bone marrow transplantation and cell therapy (SFGM-TC) organizes annually workshops in the attempt to harmonize clinical practices between different francophone transplantation center. Here, we report our recommendations regarding the management of Epstein Barr virus reactivation and lymphoproliferative disorders, cytomegalovirus (CMV) and human herpes virus 6 (HHV6) after allogeneic stem cell transplantation.

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.bulcan.2017.10.022	DOI Listing

Publication Analysis

Top Keywords

cmv human

allogeneic stem

stem cell

cell transplantation

[how manage

manage ebv

ebv reactivation

reactivation ebv-ptld

ebv-ptld cmv

human herpesvirus 6 reactivation

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!